lasofoxifene has been researched along with 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol in 1 studies
| Studies (lasofoxifene) | Trials (lasofoxifene) | Recent Studies (post-2010) (lasofoxifene) | Studies (4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol) | Trials (4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol) | Recent Studies (post-2010) (4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol) |
|---|---|---|---|---|---|
| 88 | 14 | 24 | 76 | 0 | 32 |
| Protein | Taxonomy | lasofoxifene (IC50) | 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol (IC50) |
|---|---|---|---|
| Phospholipase D2 | Homo sapiens (human) | 0.044 | |
| Steroid hormone receptor ERR2 | Homo sapiens (human) | 0.768 | |
| Estrogen receptor | Homo sapiens (human) | 0.4554 | |
| Progesterone receptor | Homo sapiens (human) | 0.0008 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 9.3325 | |
| Estrogen receptor | Mus musculus (house mouse) | 0.0332 | |
| Estrogen-related receptor gamma | Homo sapiens (human) | 0.3485 | |
| Estrogen-related receptor gamma | Mus musculus (house mouse) | 0.6 | |
| Platelet-activating factor acetylhydrolase | Homo sapiens (human) | 0.0005 | |
| Phospholipase D1 | Homo sapiens (human) | 4.8 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.0527 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bischoff, SF; Buhl, T; Floersheim, P; Fournier, B; Halleux, C; Kallen, J; Keller, H; Renaud, J; Schlaeppi, JM; Stark, W | 1 |
1 other study(ies) available for lasofoxifene and 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
| Article | Year |
|---|---|
Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
Topics: Administration, Oral; Animals; Binding Sites; Biological Availability; Cell Division; Crystallography, X-Ray; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; HeLa Cells; Humans; Isoquinolines; Ligands; Models, Molecular; Radioligand Assay; Raloxifene Hydrochloride; Rats; Receptors, Estrogen; Stereoisomerism; Structure-Activity Relationship; Transcription, Genetic; Tumor Cells, Cultured | 2003 |